Skip to main content
. 2021 Jan 23;66(7):659–669. doi: 10.1038/s10038-021-00902-4

Table 2.

Participants’ attitudes and knowledge about prenatal testing and people with trisomy 21

n = 114
Number % of all
Experience
Prenatal testing in a prior pregnancy
 Yes 7 6.1%
 No 107 93.9%
Had someone in their vicinity with T21 or talked with people of T21
 Yes 40 35.1%
 No 74 64.9%
Prenatal testing in this pregnancy
 None 65 57.0%
 NIPT 26 22.8%
 MSS 22 19.3%
 AC/CVS 1 0.9%
Attitudes
Preference on brochures of prenatal testing at the first visit
 Wanted to receive 77 67.5%
 Neither 28 24.6%
 Did not want to receive 1 0.9%
 Don’t know 8 7.0%
Planned prenatal testing at questionnaire
 No testing 34 29.8%
 Undecided 33 28.9%
 Will have testing 47 41.2%
Needed agreement with the partner for prenatal testing
 Yes 89 78.1%
 Neither 9 7.9%
 No 14 12.3%
 Don’t know 2 1.8%
Want to have GC with husband
 Yes 104 91.2%
 No 10 8.8%
Knowledge
Aware of prenatal testing before this pregnancy
 Yes 97 85.1%
 No 17 14.9%
Aware of GC
 Yes 27 23.7%
 No 87 76.3%
Understanding of the mechanism of T21
 Not an inherited disease 58 50.9%
 Inherited disease or don’t know 56 49.1%
Understanding of the average of life expectancy of T21
 ≥40 years old 48 42.1%
 40 years old or don’t know 66 57.9%
Recognition of MAE-related disorders
 Yes 105 92.1%
 No 9 7.9%

AC amniocentesis, CVS chorionic villus sampling, GC genetic counseling, NIPT noninvasive prenatal testing, MAE maternal age effect, MSS maternal serum screening, T21 trisomy 21